Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research
RESEARCH

AD HYPOTHESES
Our collection of virtual seminars, on-line journal club discussions, recorded talks and other presentations on the Forum web site that describe a variety of scientific hypotheses about the pathogenesis of Alzheimer's disease. Readers are invited to submit their own hypotheses and especially to consider and debate how this diversity of ideas and data could be integrated into a more complete picture of the disease.

The Hypothesis Factory is devoted to the presentation and exchange of ideas regarding novel hypotheses, hunches, theories-in-progress, etc. This is a forum where people with original or unconventional ideas can publicly present and discuss them.



FORUMS
As with any active field of inquiry, Alzheimer research is constantly producing novel discoveries, not to mention its share of simmering disputes, controversies and conflagrations. We host regular Live Discussions to explore hot topics with leading investigators. Each discussion includes a written review of the issue, posted comments and a scheduled live chat event, which is free to all.

In our Interviews, we ask opinion leaders to discuss and critique their favorite hypotheses, set out priorities for research, and dream a bit about what they would do if they had unlimited funding.



ENABLING TECHNOLOGIES
The Alzheimer Research Forum is involved with organizing an annual invitation-only workshop on Enabling Technologies for Alzheimer Disease Research. Summaries and recommendations are posted under Workshops, and readers are invited to comment and follow up on recommendations. Research Tools offers an index of web sites with information, downloadable software, databases and other web-based technologies for AD research.


COMPENDIA
To help researchers stay up to date and have one-stop access to important resources, we have compiled these databases and listings. These currently include a searchable database of antibodies used in Alzheimer disease research; a list of genes that have been investigated for a role in AD and related disorders; lists of mutations in the three known familial Alzheimer disease genes and in frontotemporal dementia (FTDP-17); a directory of transgenic mouse models; and a list of patents on AD-relevant laboratory reagents, methods, genes, transgenics, diagnostics and therapeutics.


RESOURCES
Practical information for the Alzheimer researcher, including postings of academic and commercial jobs; conferences; a library index of online journals; and federal and foundation grants that provide funding for AD research.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Polls
 
Should the FDA be allowed to use data from overseas clinical trials?

Absolutely, we are running out of viable subjects in the U.S.
 9
 
Yes, so long as the data is reliable
 31
 
No, the trials are not as rigorous
 3
 
No, the data should be repeated in the U.S.
 5
 
No, the drug sponsors are just trying to cut corners
 3
 
Responses: 51
 
 
 
 
 
Archived Polls
 
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad